10 days ago
LLY
AnalystsMohit BansalMohit Bansal's Stock Forecasts
AnalystsMohit Bansal
Analyst Ranking
Top 12%
#512 out of 4237 analysts
Average Return
+9.88%
Win Rate
58%28 out of 48
Risk vs Reward
Poor
Good
Mohit Bansal's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Avexis IncAVXS | +199.09% | $72.83 | $217.83 | 2017-05-22 - 2018-05-15 | Strong Buy |
Avantor IncAVTR | +175.70% | $10.41 | $28.70 | 2020-03-19 - 2021-03-19 | Strong Buy |
Avexis IncAVXS | +127.47% | $95.76 | $217.83 | 2017-10-01 - 2018-05-15 | Strong Buy |
Adaptimmune Therapeutics PLCADAP | +65.88% | $3.40 | $5.64 | 2020-04-26 - 2021-04-27 | Strong Buy |
Vertex Pharmaceuticals IncVRTX | +54.18% | $208.41 | $321.32 | 2021-12-08 - 2022-12-08 | Strong Buy |
Mohit Bansal Analyst Color
Get additional color on Mohit Bansal's coverage of popular stocks
a month ago
LLY
3 months ago
PFE
5 months ago
PFE
5 months ago
MRK
7 months ago
LLY
a year ago
PFE
a year ago
ABBV
a year ago
MRK
a year ago
PFE
Mohit Bansal's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Eli Lilly & CoLLY | 9 | Strong Buy | $500.00 | +13.04% | Maintains | 10 days ago |
Neurocrine Biosciences IncNBIX | 4 | Hold | $110.00 | +19.15% | Maintains | a month ago |
Cerevel Therapeutics Holdings IncCERE | 3 | Strong Buy | $30.00 | -10.13% | Upgrades | a month ago |
Travere Therapeutics IncTVTX | 1 | Strong Buy | $24.00 | +25.98% | Maintains | a month ago |
Abbvie IncABBV | 3 | Strong Buy | $195.00 | +42.47% | Maintains | a month ago |
Regeneron Pharmaceuticals IncREGN | 8 | Strong Buy | $915.00 | +23.66% | Maintains | 2 months ago |
Pfizer IncPFE | 6 | Hold | $44.00 | +14.70% | Maintains | 3 months ago |
Halozyme Therapeutics IncHALO | 3 | Strong Buy | $48.00 | +42.98% | Maintains | 3 months ago |
Merck & Co IncMRK | 6 | Hold | $115.00 | +2.20% | Downgrades | 3 months ago |
Amgen IncAMGN | 5 | Strong Buy | $265.00 | +21.52% | Upgrades | 3 months ago |
Mineralys Therapeutics IncMLYS | 1 | Strong Buy | $27.00 | +83.42% | Initiates Coverage On | 3 months ago |
Bristol Myers Squibb CoBMY | 4 | Hold | $78.00 | +18.79% | Maintains | 5 months ago |
Gilead Sciences IncGILD | 5 | Hold | $90.00 | +15.55% | Maintains | 5 months ago |
Xenon Pharmaceuticals IncXENE | 1 | Strong Buy | $50.00 | +28.34% | Initiates Coverage On | 6 months ago |
Vertex Pharmaceuticals IncVRTX | 4 | Strong Buy | $335.00 | +0.37% | Maintains | 7 months ago |
Biogen IncBIIB | 5 | Strong Buy | $350.00 | +16.59% | Maintains | 8 months ago |
9 Meters Biopharma IncNMTR | 1 | Strong Buy | $60.00 | N/A | Initiates Coverage On | 2 years ago |
Forte Biosciences IncFBRX | 1 | Strong Buy | $75.00 | N/A | Initiates Coverage On | 2 years ago |
Gracell Biotechnologies IncGRCL | 1 | Strong Buy | $35.00 | N/A | Initiates Coverage On | 2 years ago |
Radius Health IncRDUS | 1 | Strong Buy | $30.00 | N/A | Maintains | 2 years ago |
Alexion Pharmaceuticals IncALXN | 1 | Hold | $175.00 | N/A | Downgrades | 2 years ago |
Shattuck Labs IncSTTK | 1 | Strong Buy | $36.00 | N/A | Initiates Coverage On | 3 years ago |
Myokardia IncMYOK | 1 | Hold | $225.00 | N/A | Downgrades | 3 years ago |
Biomarin Pharmaceutical IncBMRN | 1 | Hold | $86.00 | N/A | Downgrades | 3 years ago |
Adaptimmune Therapeutics PLCADAP | 1 | Strong Buy | $5.00 | N/A | Maintains | 3 years ago |
Calithera Biosciences IncCALA | 2 | Strong Buy | $140.00 | N/A | Maintains | 3 years ago |
Avantor IncAVTR | 1 | Strong Buy | $11.00 | N/A | Maintains | 3 years ago |
Audentes Therapeutics IncBOLD | 2 | Hold | $28.00 | N/A | Maintains | 4 years ago |
Avexis IncAVXS | 2 | Strong Buy | $116.00 | N/A | Maintains | 6 years ago |
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.